Brief: Hanall Biopharma Q3 Operating Profit 1.1 Billion Won, Down 45% From Year Earlier
26/10/2022 07:59
Hanall Biopharma Co Ltd 009420.KS :
* HANALL BIOPHARMA: Q3 OPERATING PROFIT 1.1 BILLION WON,
DOWN 45%
FROM YEAR EARLIER
Source text for Eikon: ID:
Further company coverage: 009420.KS
Recent news on Hanall Biopharma
See all newsQ2 2026 Operating Profit Up 567.4% QoQ, 388.5% YoY To Won 5.60 Billion
Brief: Hanall Biopharma Co Icc Rules Licensing Deal With Harbour Biomed Continues To Be Effective
Brief: Hanall Biopharma Q1 Operating Profit 839 Million Won, Swings To Profit From Year Earlier
Immunovant falls as drug for thyroid eye disease fails late-stage trials
Immunovant falls as eye disease therapy fails in late-stage studies